Viewing Study NCT06552234


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-27 @ 11:49 PM
Study NCT ID: NCT06552234
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module